*ST Meigu (000615.SZ): Net profit for the first quarter - 239.587 million yuan

Gelonghui, April 26丨*ST Meigu (000615.SZ) released its report for the first quarter of 2024, achieving operating income of 275 million yuan, a year-on-year decrease of 15.63%; net profit attributable to shareholders of listed companies - 239.587 million yuan, net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 26.3547 million yuan, and basic earnings per share - 0.0314 yuan.

Gelonghui FinanceApr 26 07:28

*ST Meigu (000615.SZ) announced first-quarter results, net loss of 239.587 million yuan

*ST Beauty Valley (000615.SZ) released its report for the first quarter of 2024, achieving 2 operating income during the reporting period...

Zhitong FinanceApr 26 01:03

Express News | *ST Mitani: Settlement agreement signed with Cinda Asset Management

BreakingsApr 2 17:25

*ST Meigu (000615.SZ) plans to acquire 3.2% of Liantianmei's shares to resolve follow-up performance compensation issues

Zhitong Finance App News, *ST Beauty Valley (000615.SZ) announced that the company plans to acquire 3.2% of the shares of Zhejiang Liantianmei Enterprise Management Co., Ltd. (“Lian Tianmei Company”) held by the unrelated party Guangzhou Shengzhuang Medical Beauty Investment Co., Ltd. (“Shengzhuang Medical Beauty”) for 32.3771 million yuan, and adjust Shengzhuang Medical Beauty's performance compensation method for the target company from a cash method to the method of cash and the aforementioned share transfer compensation. After all transactions were completed, Shengzhuang Medical & Aesthetic's performance compensation obligations were fulfilled. The total shareholding ratio of the company's holding subsidiaries in Lian Tianmei Company

Zhitong FinanceMar 15 20:57

*ST Beauty Valley (000615.SZ): Some medical and aesthetic consumables are Huaxi Biotech products

Gelonghui March 5 | An investor asked *ST Meigu (000615.SZ) on the investor interactive platform, “How are your company's cooperation discussions with Huaxi Biotech?” The company replied that some of the company's medical and aesthetic consumables are Huaxi Biotech products.

Gelonghui FinanceMar 5 16:27

*ST Meigu (000615.SZ): The company is actively following the restructuring process of Aoyuan in China

Glonghui December 26丨*ST Meigu (000615.SZ) said on the investor interactive platform on December 26 that the company is actively following the restructuring process of Aoyuan in China.

Gelonghui FinanceDec 26, 2023 10:06